Projected Earnings Date: 2024-08-12    (Delayed quote data   2025-05-09)
Last
 4.40
Change
 ⇑ +0.14   (+3.29%)
Volume
  6,841
Open
 4.26
High
 4.48
Low
 4.23
8EMA (Daily)
 3.47
40EMA (Daily)
 1.41
50EMA (Daily)
 1.24
STO (Daily)
 81.257
MACD Hist (Daily)
 0.819
8EMA (Weekly)
 2.023
40EMA (Weekly)
 1.28
50EMA (Weekly)
 1.44
STO (Weekly)
 35.273
MACD Hist (Weekly)
 0.949
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license or acquire unique and non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's first product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, non-implantable medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise. The company derives its revenue from Product Sales, fees and; license sources.
optionchance optionchance
Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com